Device type · DDG
Transferrin, Antigen, Antiserum, Control
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DDG
Immunology
Device class
Class II
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
1
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Transferrin, Antigen, Antiserum, Control
- Product code
- DDG
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5880
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DDG
Latest FDA decisions
- Access sTfR510(k)
K240987 · Decided Jul 3, 2024 · 84 days after receipt
Device type: Transferrin, Antigen, Antiserum, Control (DDG) · Laboratory Medicine & Pathology
- Transferrin510(k)
K190495 · Decided Mar 16, 2020 · 382 days after receipt
Device type: Transferrin, Antigen, Antiserum, Control (DDG) · Laboratory Medicine & Pathology
Roche Diagnostics Operations (Rdo)
K182095 · Decided Nov 5, 2018 · 94 days after receipt
Device type: Transferrin, Antigen, Antiserum, Control (DDG) · Laboratory Medicine & Pathology
Reports received
1
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Non Reproducible Results1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1422-2022 · Started Jun 9, 2022
Reason given: A customer reported a problem with the reagent and calibrator. Randox Laboratories carried out an investigation and confirmed the issue. The complaint is pertaining to atypical calibration curves that can results in non-numerical results. This affects Siemens Atellica CH analysers only. Customer have reported an...
Cause as FDA categorized it: Under Investigation by firm
Z-1423-2022 · Started Jun 9, 2022
Reason given: A customer reported a problem with the reagent and calibrator. Randox Laboratories carried out an investigation and confirmed the issue. The complaint is pertaining to atypical calibration curves that can results in non-numerical results. This affects Siemens Atellica CH analysers only. Customer have reported an...
Cause as FDA categorized it: Under Investigation by firm
Roche Diagnostics Operations, Inc.
Z-0108-2020 · Started Aug 28, 2019
Reason given: Tina-quant Soluble Transferrin Receptor (STFR) Assays Updated Claims for Rheumatoid Factors Interference
Cause as FDA categorized it: Under Investigation by firm
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.